
Parmax Pharma Ltd is Rated Sell
2026-11-20 10:10:35Parmax Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 10 August 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 20 November 2026, providing investors with an up-to-date analysis of the company’s standing.
Read More
Parmax Pharma Ltd is Rated Sell
2026-11-01 10:10:05Parmax Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 10 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 November 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.
Read MoreParmax Pharma Stagnates at Rs.139.10 Despite Market Volatility: Key Weekly Insights
2026-10-10 13:02:03Key Events This Week 05 Oct: Parmax Pharma Ltd hits new 52-week and all-time high at Rs.139.10 06-09 Oct: Stock price remains unchanged at Rs.139.10 despite Sensex volatility 09 Oct: Week closes flat at Rs.139.10, outperforming Sensex which fell 0.57% Week OpenRs.139.10 Week CloseRs.139.10+0.00%</d...
Read More
Broad-Based Technical Strength Lifts Parmax Pharma Ltd to 52-Week High of Rs 139.1
2026-10-05 10:44:33From a 52-week low of Rs 22.6 to a new peak of Rs 139.1 on 05 Oct 2026, Parmax Pharma Ltd has surged an impressive 515% over the past year, defying the broader market’s downward trend and showcasing remarkable price momentum.
Read MoreParmax Pharma Gains 0.99% Amid Market Decline: 2 Key Milestones Define Week
2026-10-03 13:02:00Key Events This Week Sep 28: New 52-week high and all-time high at Rs.137.75 Sep 29 - Oct 01: Price consolidation at Rs.137.75 amid declining Sensex Oct 02: No trading data available; week closes with stock outperforming Sensex Week Open Rs.136.40 Week Close ...
Read More
Parmax Pharma Ltd is Rated Sell
2026-09-28 10:10:05Parmax Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 10 August 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 28 September 2026, providing investors with an up-to-date analysis of the company’s standing.
Read MoreParmax Pharma Gains 1.00%: Key Milestones and Market Dynamics This Week
2026-09-26 13:02:28Key Events This Week 21 Sep: Parmax Pharma Ltd hits new 52-week and all-time high at Rs.136.40 22 Sep: Stock price remains steady at Rs.136.40 amid Sensex decline 23 Sep: Price unchanged at Rs.136.40 as Sensex gains 0.56% 24 Sep: Stock price flat at Rs.136.40 despite Sensex falling 1.62% 25 Sep: Week closes at Rs.136.40 with Sensex modestly up 0.18% Week Open</di...
Read MoreNon-Applicability Of Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
19-Nov-2026 | Source : BSEIn pursuant to Reg 23(9) the paid up capital and networth of the company does not exceed in Financial year 31st march 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
18-Nov-2026 | Source : BSENewspaper publication for Financial Results for quarter and half year ended 30.09.2026
Unaudited Financial Results For Quarter And Half Year Ended 30.09.2026
16-Nov-2026 | Source : BSEUnaudited Financial results for quarter and half year ended 30.09.2026
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available

